Fundology

NYSE: HCA · Health Services

Which UK funds hold HCA Healthcare, Inc. (HCA)?

HCA Healthcare, Inc. (HCA) is not among the ten largest holdings of any UK fund Fundology covers. It appears further down the published holdings of 134 funds. 33 swap-based funds also list HCA Healthcare, Inc. (HCA) in the substitute baskets they hold as collateral; they track different indices through swaps and are not counted as holders.

UK funds that hold HCA Healthcare, Inc.

No covered fund lists this company today

Many funds publish only their ten largest positions, so a fund can own a company without it appearing here.

Funds that hold it further down

134 more funds list HCA Healthcare, Inc. below their ten largest holdings.

Create a free account to see every fund that holds this company, at any weight

Sign-up takes an email address. There is no card to enter and nothing to pay.

About HCA Healthcare, Inc.

HCA Healthcare, Inc. is listed on NYSE under the symbol HCA, in the health services sector. Its market value was about $104.2bn (in US dollars) on 13/11/2026.

A fund’s weight in a company is the share of the fund’s money held in that company’s shares. A weight of 5% in a fund worth £1 billion is about £50 million. Index funds hold companies in proportion to their size in the index, so the largest companies appear in many funds at similar weights.

The list above is drawn from the funds’ published holdings, each dated, and names the funds where HCA Healthcare, Inc. is one of the ten largest holdings — the part of every fund page open to anyone. Some funds publish only their largest ten, so a fund can hold HCA Healthcare, Inc. without it appearing in any list here. When two funds both hold the same large companies, owning both can be closer to owning one than it looks: the comparison page measures that overlap when both funds publish enough of their holdings.

Share price

Latest price
$499.05
−0.32%on the day
52-week range
$353.99–$556.52
Price change, 1 year
+6.2%
Price change, this year
+7.1%
Market value
$104.2bn
Price to earnings (12 months)
16.5
Dividend yield (12 months)
0.61%

As of , at least 15 min delayed